Page 2 - Carlyle

Private equity fund Carlyle partners with Viyash for generics platform

Global private equity major Carlyle on Tuesday said it has set up a generic pharmaceutical platform in the country by partnering with Viyash Life Sciences. CA Hull Investments, an affiliated entity of CAP V Mauritius and Carlyle, and Viyash, have set up the platform, an official statement said, without giving any details of any investments. Viyash was set up by Hari Babu in partnership with Srihari Raju Kalidindi, and is a manufacturer of API (active pharmaceutical ingredients) intermediates, it said. Carlyle had first partnered with Viyash in June this year, during the latter's acquisition of majority stake in Symed Labs, a leading manufacturer of niche APIs to enable backward integration. Viyash has also acquired a controlling stake in Appco Pharma LLC, a formulations player focused on the US market which will help expand access to US generics market and formulation capabilities, the statement said. The company now has ten manufacturing facilities in India with a combined capaci

Blackstone's Amit Jain jumps ship to rival Carlyle as India co-head of PE

At Blackstone, Jain sat on the boards of Essel Propack, Aakash Educational Services, Sona Comstar, Fino Payments Bank

Medanta IPO: Co-founder Sunil Sachdeva and Carlyle to offload stake

Anant Investments, an affiliate of private equity major Carlyle Group, expects to offload around 4.33 crore equity shares in the offer for sale

No error of judgment in PNB Housing-Carlyle deal: PNB MD Mallikarjuna Rao

Subsequent rise in share prices of the mortgage lender post the announcement could not have been anticipated, he asserts

Top headlines: Team Modi to meet after reshuffle, Adani to raise $1.5 bn

Prime Minister Modi expands and reshuffles his team of ministers; Shapoorji Pallonji group says it doesn't need Tata approval to pledge its shares in the conglomerate.

Explained: Why red flags have gone up on PNB Housing-Carlyle deal

What are the contours of the deal? Why is the market regulator hesitant about giving the deal a go-ahead? In today's podcast we decode them and more

SBI Cards' shares fall by 6.7% as PE giant Carlyle sells 5.1% stake

Carlyle sold 48 million shares at Rs 1,002 apiece to raise Rs 4,810 crore.

PE major Carlyle to sell 5.1% stake in SBI Cards on Friday

A total of 48 million shares of the credit card company will be on offer in the range between Rs 1,002 to Rs 1,041.3 per share

Regulators to look into PNB Housing Fin's plan to raise Rs 4,000 cr

The company's board has cleared a proposal to raise up to Rs 4,000 crore by issuing preference shares and convertible warrants to Carlyle Group firms and other entities.

After 26 yrs as HDFC Bank boss, Aditya Puri joins Carlyle as senior advisor

Puri, who retired from HDFC recently will provide the global investment firm guidance on investment opportunities across Asia

Carlyle, SoftBank put on waiting list for Reliance Retail stake: Report

Reliance Industries plans to sell about a 10% stake in Reliance Retail to financial investors and almost all the $5.7 billion worth of shares have been taken up

Amazon, Carlyle, Brookfield vie for Biyani's Future Supply Chain Solutions

Future Supply Chain Solutions (FSC) is a third-party supply chain and logistics service provider that offers warehousing facilities also.

Carlyle explores sale of vitamin maker Nature's Bounty

Carlyle has held talks with potential advisers about selling the Ronkonkoma